Certara LP Acquired by Arsenal Capital Partners

Thursday, December 19, 2013

William Blair & Company acted as the exclusive financial advisor to Certara LP, a portfolio company of Vector Capital, in connection with the sale of Certara to Arsenal Capital Partners for an undisclosed amount. The transaction closed on December 18, 2013, and represents William Blair’s 85th transaction in healthcare IT and 33rd transaction in outsourced biopharmaceutical services in the last 10 years.

Transaction Highlights

  • Natural fit with William Blair’s HCIT and outsourced biopharmaceutical services platforms: William Blair’s combined knowledge of the healthcare IT and outsourced biopharmaceutical services sectors, as well as our strong relationships with and insight into likely acquirers, created unmatched value for Vector and Certara. 
  • Execution excellence: William Blair’s HCIT and outsourced biopharmaceutical services teams marketed Certara to a comprehensive group of potential acquirers, coordinated a due diligence process, and successfully led a competitive negotiation of key transaction terms. 
  • Trusted guidance: William Blair’s senior deal team was integrally involved in each step of the transaction process and facilitated an exceptional outcome for Vector and Certara.

About the Companies

Certara is the leading provider of model-based drug development (MBDD) and data analytics software and consulting services in the biopharmaceutical research and development market. With capabilities in discovery, pre-clinical, and clinical software as well as its D360 informatics solution, Certara has an end-to-end platform that serves the entire drug development market.

Vector is a leading global private equity firm specializing in spinouts, buyouts, and recapitalizations of established technology businesses. Vector actively partners with management teams to devise and execute new financial and business strategies that materially improve the competitive standing of these businesses and enhance their value for employees, customers, and shareholders.

Arsenal is a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies. The firm targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities.

News Alerts

Stay connected to your favorite publications and news features.

Subscribe Now